Sitryx Therapeutics
Boston, United States· Est.
Sitryx Therapeutics focuses on modulating cellular metabolism to develop treatments for autoimmune diseases and cancer.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $39M
About
Sitryx Therapeutics focuses on modulating cellular metabolism to develop treatments for autoimmune diseases and cancer.
ImmunologyOncologyMetabolic
Funding History
1Total raised:$39M
Series A$39M